Event dossier

Experimental pancreatic cancer pill doubles survival chances, boosts quality of life

Daraxonrasib reduced the overall risk of death by 60 per cent compared with chemotherapy.

1 report1 sourceMay 31, 2026, 1:13 PM
FilterThe Straits Times
Clustered coverageThe Straits Times
Coverage timeline1
Coverage timeline

Coverage timeline

Ranked reports inside the event cluster. Open any publisher link to read the original coverage.

The Straits TimesMay 31, 2026, 1:13 PM

Experimental pancreatic cancer pill doubles survival chances, boosts quality of life

Daraxonrasib reduced the overall risk of death by 60 per cent compared with chemotherapy.

Related events

Related events

Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.